Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: Tomato who wrote (632)	11/17/2001 11:39:43 AM
From: scaram(o)uche	Respond to of 1833

>> at a ratio that values the stock at 3 times market value << Exactly. For equity in a hot, small biotech that needs diversification (Axiom, OSIP-Solvay, OSIP-proprietary) and cheap cash. A win-win for the companies, and shareholders get to ride the new fast pony if they like. Nice to see that 3X figure, as that seems very "doable". TELK was just an example that I used due to the modest secondary while cash was rare. Just as at this time last year, I hope that news breaks at any moment. ;-)